These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8485905)

  • 1. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.
    Ross GD; Vĕtvicka V
    Clin Exp Immunol; 1993 May; 92(2):181-4. PubMed ID: 8485905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
    Vetvicka V; Thornton BP; Ross GD
    J Clin Invest; 1996 Jul; 98(1):50-61. PubMed ID: 8690804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.
    Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD
    Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).
    Vetvicka V; Thornton BP; Wieman TJ; Ross GD
    J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents.
    Muto S; Vĕtvicka V; Ross GD
    J Clin Immunol; 1993 May; 13(3):175-84. PubMed ID: 8100571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18).
    Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP
    J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.
    Klein E; Di Renzo L; Yefenof E
    Mol Immunol; 1990 Dec; 27(12):1343-7. PubMed ID: 1980339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18).
    Di Renzo L; Yefenof E; Klein E
    Eur J Immunol; 1991 Jul; 21(7):1755-8. PubMed ID: 2060581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes.
    Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z
    Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein.
    Ross GD
    Crit Rev Immunol; 2000; 20(3):197-222. PubMed ID: 10968371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation.
    Zhou MJ; Brown EJ
    J Cell Biol; 1994 Jun; 125(6):1407-16. PubMed ID: 7515890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic intervention with complement and beta-glucan in cancer.
    Ross GD; Vetvicka V; Yan J; Xia Y; Vetvicková J
    Immunopharmacology; 1999 May; 42(1-3):61-74. PubMed ID: 10408367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologia Futura: stories about the functions of β
    Bajtay Z
    Biol Futur; 2021 Mar; 72(1):7-13. PubMed ID: 34554501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A-domain of beta 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF.
    Rieu P; Ueda T; Haruta I; Sharma CP; Arnaout MA
    J Cell Biol; 1994 Dec; 127(6 Pt 2):2081-91. PubMed ID: 7528750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells.
    Fossati-Jimack L; Ling GS; Cortini A; Szajna M; Malik TH; McDonald JU; Pickering MC; Cook HT; Taylor PR; Botto M
    PLoS One; 2013; 8(2):e57082. PubMed ID: 23451151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18).
    Xia Y; Ross GD
    J Immunol; 1999 Jun; 162(12):7285-93. PubMed ID: 10358177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Immunology of Complement Receptors 3 and 4.
    Vorup-Jensen T; Jensen RK
    Front Immunol; 2018; 9():2716. PubMed ID: 30534123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
    Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
    J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.